Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Celgene Corp., consolidated cash flow statement

US$ in millions

12 months ended:	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Net income	4,046)	2,940)	1,999)	1,602)	2,000)
Depreciation	160)	134)	121)	115)	104)
Amortization	475)	337)	384)	294)	269)
Impairment charges	31)	1,679)	489)	49)	133)
Deferred income taxes	32)	(1,330)	(344)	(33)	(272)
Change in value of contingent consideration and success payments	19)	(1,350)	21)	(8)	49)
Gain on sale of business	—)	—)	(38)	—)	—)
Net (gain) loss on sales of debt securities available-for-sale and equity investments	18)	(61)	(7)	(84)	5)
Fair value adjustments on equity investments	(317)	—)	—)	—)	—)
Share-based compensation expense	921)	644)	606)	577)	448)
Share-based employee benefit plan expense	33)	34)	40)	35)	41)
Derivative instruments	3)	72)	169)	(31)	(72)
Other, net	(15)	(24)	(10)	19)	(14)
Accounts receivable	(178)	(236)	(222)	(305)	(166)
Inventory	82)	(42)	(55)	(51)	(57)
Other operating assets	(55)	(73)	94)	(326)	53)
Accounts payable and other operating liabilities	290)	273)	619)	533)	252)
Income tax payable	(393)	2,229)	112)	61)	39)
Payment of contingent consideration	(22)	—)	(9)	—)	(14)
Deferred revenue	41)	20)	7)	37)	8)
Change in current assets and liabilities, excluding the effect of acquisitions	(235)	2,171)	546)	(50)	115)
Adjustments to reconcile net income to net cash provided by operating activities	1,125)	2,306)	1,977)	882)	806)
Net cash provided by operating activities	5,171)	5,246)	3,976)	2,484)	2,806)
Proceeds from sales of debt securities available-for-sale	3,388)	5,872)	633)	3,800)	2,176)
Purchases of debt securities available-for-sale	(675)	(8,163)	(1,281)	(1,889)	(2,661)
Capital expenditures	(330)	(279)	(236)	(286)	(150)
Proceeds from sales of equity investment securities	96)	116)	15)	92)	—)
Purchases of equity investment securities	(249)	(410)	(132)	(273)	(67)
Payments for acquisition of businesses, net of cash acquired	(8,648)	—)	—)	(7,695)	(710)
Other investing activities	—)	(27)	(1)	(7)	(25)
Net cash used in investing activities	(6,418)	(2,891)	(1,002)	(6,259)	(1,438)
Payment for treasury shares	(6,096)	(3,833)	(2,160)	(3,257)	(2,975)
Proceeds from short-term borrowing	5,709)	—)	100)	6,112)	2,567)
Principal repayments on short-term borrowing	(5,709)	—)	(100)	(6,213)	(3,012)
Proceeds from the issuance of long-term debt	4,452)	3,468)	—)	7,913)	2,471)
Repayments of long-term debt	—)	(1,904)	—)	(514)	—)
Net proceeds (payments) from common equity put options	—)	—)	8)	(9)	10)
Payment of contingent consideration	(40)	—)	(41)	—)	(26)
Net proceeds from share-based compensation arrangements	144)	685)	359)	252)	297)
Excess tax benefit from share-based compensation arrangements	—)	—)	189)	301)	251)
Net cash provided by (used in) financing activities	(1,540)	(1,584)	(1,646)	4,585)	(417)
Effect of currency rate changes on cash and cash equivalents	8)	72)	(39)	(51)	(64)
Net increase (decrease) in cash and cash equivalents	(2,779)	843)	1,290)	759)	887)
Cash and cash equivalents at beginning of period	7,013)	6,170)	4,880)	4,122)	3,234)
Cash and cash equivalents at end of period	4,234)	7,013)	6,170)	4,880)	4,122)

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).

Download chart

Cash flow statement item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Celgene Corp. net cash provided by operating activities increased from 2016 to 2017 but then slightly decreased from 2017 to 2018.
Net cash used in investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Celgene Corp. net cash used in investing activities decreased from 2016 to 2017 and from 2017 to 2018.
Net cash provided by (used in) financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Celgene Corp. net cash provided by (used in) financing activities increased from 2016 to 2017 and from 2017 to 2018.

Celgene Corp. (NASDAQ:CELG)

Cash Flow Statement